Publicacións en colaboración con investigadores/as de Harvard Medical School (11)

2023

  1. Locus for severity implicates CNS resilience in progression of multiple sclerosis

    Nature

  2. The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients

    European Journal of Neurology, Vol. 30, Núm. 8, pp. 2401-2410

2021

  1. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

2020

  1. A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis

    Multiple Sclerosis Journal, Vol. 26, Núm. 9, pp. 1074-1082

  2. Amendment on the article “Missing outcome data management in acute stroke trials testing iv thrombolytics: Is there risk of bias?”

    European Stroke Journal

  3. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

    The Lancet Neurology

  4. Missing outcome data management in acute stroke trials testing iv thrombolytics. Is there risk of bias?

    European Stroke Journal, Vol. 5, Núm. 2, pp. 148-154

  5. Sex effects across the lifespan in women with multiple sclerosis

    Therapeutic Advances in Neurological Disorders, Vol. 13

2017

  1. Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke

    Neuroradiology, Vol. 59, Núm. 4, pp. 343-351

2015

  1. Do surgeons treat their patients like they would treat themselves?

    Clinical Orthopaedics and Related Research, Vol. 473, Núm. 11, pp. 3564-3572

2014

  1. Biomechanical studies: Science (f)or common sense?

    Injury, Vol. 45, Núm. 12, pp. 2035-2039